Newsfeeds Archive - Page 2 of 14

3 minute read

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

April 16, 2:17 PM

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.

ACDC

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

April 16, 12:31 PM

Gainers Palisade Bio (NASDAQ:PALI) stock increased by 65.1% to $6.87 during Tuesday’s regular session. The company’s market cap…

ANL

3 minute read

Gold Moves Higher; Morgan Stanley Earnings Top Views

By Avi Kapoor

April 16, 12:11 PM

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 0.2% on Tuesday. The Dow traded up 0.13% to 37,784.21 while the NASDAQ fell 0.20% to 15,853.34. The S&P 500 also fell, dropping, 0.29% to 5,047.11.

BNED

2 minute read

Movers
News

Why Palisade Bio Stock Is Soaring Today

By Erica Kollmann

April 16, 11:47 AM

Palisade Bio shares are trading higher Tuesday after the company announced the completion of its analysis evaluating ex-vivo bioactivation of PALI-2108. Palisade Bio said the findings demonstrated PALI-2108 exhibited efficient ex-vivo conversion into its active PDE4 inhibitor form in stool samples from both normal healthy volunteers and patients with ulcerative colitis (UC). The assessment showed PALI-2108 was converted into its active PDE4 inhibitor form at a mean rate of 90.1% with conversion steadily increasing over time.

PALI

3 minute read

Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit

By Avi Kapoor

April 16, 9:48 AM

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.35% to 37,865.71 while the NASDAQ fell 0.13% to 15,865.09. The S&P 500 also fell, dropping, 0.12% to 5,055.53.

BAC

1 minute read

Palisade Bio Presents Development Overview Of PALI-2108 At The IBD Innovate: Product Development For Crohn’s & Colitis April 9-10, 2024 In Cambridge, MA

By Benzinga Newsdesk

April 10, 8:16 AM

– PALI-2108 in development for the treatment of moderate-to-severe ulcerative colitis (UC) advancing towards Phase 1 clinical study before year endCarlsbad, CA, April 10, 2024 (GLOBE NEWSWIRE) -- Palisade Bio,

PALI

4 minute read

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

January 30, 2:18 PM

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales

ADXN

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

January 30, 1:31 PM

Gainers NexImmune (NASDAQ:NEXI) stock increased by 152.8% to $23.51 during Tuesday’s regular session. The company’s market cap stands…

ADXN

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

January 29, 5:31 PM

Gainers Agape ATP (NASDAQ:ATPC) stock increased by 39.2% to $0.71 during Monday’s after-market session. The company’s market cap…

ADAP

3 minute read

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

January 29, 3:09 PM

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.

ACON